Therapix Biosciences needs a big market-cap boost to realize commercial opportunities for its cannabinoid treatments for nervous-system conditions.
No cause was given for the firing of Maureen O'Connell. Except that it wasn't due to Scholastic's financial results.
A search firm details the steps it takes to fill finance-chief positions at middle-market, PE-backed companies.
Former Rio Tinto finance chief steps down from Royal Dutch Shell’s board as a result of the charges.
Three things the world has done well since the global financial crisis, and three goals yet to be achieved.
The lighter disclosure required of companies that go public under the law ends up costing them a significant chunk of cash, research finds.
Companies that are bold enough to embrace artificial intelligence will gain a big competitive advantage.
Second-quarter data for S&P 500 companies show a pullback in share repurchases compared with the first quarter.
The International Accounting Standards Board responds to companies’ call for help with materiality in financial statements.
Original equipment makers, tech companies, and suppliers are vying for control of the auto's “center stack,” which customers may value more than…